Approval · Notice of Compliance 24791 · 2020
APO-METHYLPHENIDATE: Notice of Compliance 24791
Issued December 11, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24791
- Date
- December 11, 2020
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph
- Canadian reference product
- RITALIN AND RITALIN SR (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-METHYLPHENIDATE | Not yet assigned | — |
| APO-METHYLPHENIDATE SR | Not yet assigned | — |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 5 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 10 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB